Cardio Diagnostics Holdings, Inc.

10-Q Quarter ended 2026-03-31 May 15, 2026 10-K Fiscal year ended 2025-12-31 Mar 13, 2026 8-K Regulation FD disclosure Feb 19, 2026 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Shareholder vote results Oct 15, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Other events May 28, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure May 13, 2025 10-K Fiscal year ended 2024-12-31 Mar 20, 2025 8-K Regulation FD disclosure Feb 21, 2025 8-K Delisting notice or listing-rule failure Dec 4, 2024 8-K Shareholder vote results Nov 18, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 8-K Delisting notice or listing-rule failure Jun 7, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024 8-K Regulation FD disclosure Apr 2, 2024 10-K Fiscal year ended 2023-12-31 Apr 1, 2024 8-K Unregistered sale of equity; Other events Feb 2, 2024 8-K Entered a material agreement Feb 1, 2024 8-K Terminated a material agreement Jan 4, 2024 8-K Shareholder vote results Dec 19, 2023 8-K Other events Dec 6, 2023 8-K Delisting notice or listing-rule failure Nov 22, 2023 10-Q Quarter ended 2023-09-30 Nov 13, 2023 8-K Delisting notice or listing-rule failure Sep 25, 2023 8-K/A Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Sep 14, 2023 8-K Regulation FD disclosure Sep 11, 2023 10-Q Quarter ended 2023-06-30 Aug 14, 2023 8-K Entered a material agreement; Director or officer change Jun 22, 2023 8-K/A Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Jun 5, 2023 8-K Amended charter or bylaws; Shareholder vote results May 30, 2023 8-K Regulation FD disclosure May 16, 2023 10-Q Quarter ended 2023-03-31 May 15, 2023 10-K Fiscal year ended 2022-12-31 Mar 31, 2023 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure; Other events Mar 13, 2023 8-K Changed accountants Nov 10, 2022 10-Q Quarter ended 2022-09-30 Nov 7, 2022 8-K Entered a material agreement; Completed an acquisition or disposition; Delisting notice or listing-rule failure; Modified rights of security holders; Change in control; Director or officer change; Amended charter or bylaws; Item 5.06; Shareholder vote results; Regulation FD disclosure Oct 31, 2022